about
Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancerChemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targetingGlioma cell integrin expression and their interactions with integrin antagonists: Research Article.Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.Needle-like morphology of H2K4b polyplexes associated with increases in transfection in vitro.Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?Phage L5 integrating vectors are present within the Mycobacterial Cell in an equilibrium between integrated and excised states.Cisplatin nephrotoxicity: molecular mechanisms.Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.Thiazolidinediones as anti-cancer agents.A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle.Pre-treatment with a non-therapeutic dose of cisplatin increases solid tumour response to liposomal-p53 gene therapy- An in vivo study.Stress sensor Gadd45 genes as therapeutic targets in cancer.PML: An emerging tumor suppressor and a target with therapeutic potential.Analysis of bone marrow plasma cells in patients with solitary bone plasmacytoma.siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.
P1433
Q28397449-9416296E-EB93-4576-A7C3-1648D02F90F0Q34010429-7B009CE5-3B2B-4A03-9F37-81273816B884Q34313253-2AA5AEA0-482F-4F8E-B7F8-F3EDE18FE01BQ34977081-3A1F217A-43A8-4A4D-9A99-733D628B6BC3Q35944967-EFEC64FC-C566-4F40-B587-9553FA4C0256Q35945262-D82C8FB3-B718-4C4B-8D63-0581E750D0E1Q35994863-208BFE11-0714-47E2-B500-AFE54CDB51E8Q36334357-5D6A7DC2-D668-4078-8E9C-4DF462515C07Q36713803-C80C8B12-DA1B-4D61-87F7-9730D5495770Q36974036-7C3B2592-610E-4F93-950B-DBB8A4900BA8Q37010048-A12CB326-8B92-47B1-A571-941E619DCC61Q37010188-8DA1C5BF-BF94-4AE9-8172-D0FF9F7D12E9Q37038104-AD8E6046-C630-49CC-87E8-163A111A3D81Q37151919-A73E8550-9D82-4A5E-A958-36699A8B4C9FQ39630019-E9A53C13-C0D1-48C1-AF9A-BF73E7FBA113Q41479762-BCFD623E-2ADC-4A6C-9997-1831AE9E7198Q41971647-F5FF0F18-30DE-43E7-A469-904E094D1948Q43065694-CF2AE105-2587-4F0D-A776-E302576EE396Q43230143-607EA495-B651-43F0-B254-79E8CF754C62
P1433
description
czasopismo naukowe
@pl
revista científica
@es
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Cancer therapy
@ast
Cancer therapy
@da
Cancer therapy
@de
Cancer therapy
@en
Cancer therapy
@es
Cancer therapy
@fo
Cancer therapy
@fr
Cancer therapy
@is
Cancer therapy
@kl
Cancer therapy
@nb
type
label
Cancer therapy
@ast
Cancer therapy
@da
Cancer therapy
@de
Cancer therapy
@en
Cancer therapy
@es
Cancer therapy
@fo
Cancer therapy
@fr
Cancer therapy
@is
Cancer therapy
@kl
Cancer therapy
@nb
altLabel
Cancer Ther
@da
Cancer Ther
@de
Cancer Ther
@en
prefLabel
Cancer therapy
@ast
Cancer therapy
@da
Cancer therapy
@de
Cancer therapy
@en
Cancer therapy
@es
Cancer therapy
@fo
Cancer therapy
@fr
Cancer therapy
@is
Cancer therapy
@kl
Cancer therapy
@nb
P1055
P1156
19200156925
P1476
Cancer Therapy
@en
P1813
Cancer Ther
@en
P236
P3417
Cancer-Therapy
P407
P571
2003-01-01T00:00:00Z